Search research articles
Contact Us
Filters
Showing results (711-720 of 734) with videos related to
Page
of 74
Sort By:
Annals of the ICRP
|
June 15, 2026
A multidisciplinary challenge to assess the next-generation risks of low-dose-rate long-term gamma-ray exposure by whole-genome sequencing in the mouse model
Y Gondo, A Uchimura, M Yoneya, et al.
Toxicon : Official Journal of the International Society on Toxinology
|
February 11, 2000
Regional and accelerated molecular evolution in group I snake venom gland phospholipase A2 isozymes
Y Chuman, I Nobuhisa, T Ogawa, et al.
Cancer Gene Therapy
|
September 29, 2012
Neural stem cell-based dual suicide gene delivery for metastatic brain tumors
C Wang, A Natsume, H J Lee, et al.
Ryumachi. [Rheumatism]
|
February 24, 2001
[Two cases of acute lupus peritonitis]
H Ideguchi, M Misumi, Y Inoue, et al.
Clinical and Experimental Pharmacology & Physiology
|
April 1, 2000
T-0162, a novel free radical scavenger, reduces myocardial infarct size in rabbits
K Yamashita, S Minatoguchi, Y Uno, et al.
Progress in Nucleic Acid Research and Molecular Biology
|
January 15, 1998
Molecular evolution of snake toxins: is the functional diversity of snake toxins associated with a mechanism of accelerated evolution?
M Ohno, R Ménez, T Ogawa, et al.
Circulation
|
April 15, 1997
Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease
H Morita, J Taguchi, H Kurihara, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
March 10, 1979
[Relationship between body surface isopotential distribution and transmission process of pericardial membrane excitation--with special reference to atrial septal defects]
H Oguri, T Koube, M Ohno, et al.
Journal of Cardiology
|
June 1, 1997
[Gene Polymorphism of 5, 10-methylenetetrahydrofolate reductase as a coronary risk factor]
H Morita, J Taguchi, H Kurihara, et al.
ESMO Open
|
July 10, 2026
First-in-human phase I study of hypoxia-targeting <sup>64</sup>Cu-ATSM radioligand therapy in patients with malignant brain tumors (STAR-64)
H Kurihara, Y Narita, K Ito, et al.
Page
of 74
Search research articles
Search
Showing results (711-720 of 734) with videos related to
Sort By:
Page
of 74
Annals of the ICRP
|
June 15, 2026
A multidisciplinary challenge to assess the next-generation risks of low-dose-rate long-term gamma-ray exposure by whole-genome sequencing in the mouse model
Y Gondo, A Uchimura, M Yoneya, et al.
Toxicon : Official Journal of the International Society on Toxinology
|
February 11, 2000
Regional and accelerated molecular evolution in group I snake venom gland phospholipase A2 isozymes
Y Chuman, I Nobuhisa, T Ogawa, et al.
Cancer Gene Therapy
|
September 29, 2012
Neural stem cell-based dual suicide gene delivery for metastatic brain tumors
C Wang, A Natsume, H J Lee, et al.
Ryumachi. [Rheumatism]
|
February 24, 2001
[Two cases of acute lupus peritonitis]
H Ideguchi, M Misumi, Y Inoue, et al.
Clinical and Experimental Pharmacology & Physiology
|
April 1, 2000
T-0162, a novel free radical scavenger, reduces myocardial infarct size in rabbits
K Yamashita, S Minatoguchi, Y Uno, et al.
Progress in Nucleic Acid Research and Molecular Biology
|
January 15, 1998
Molecular evolution of snake toxins: is the functional diversity of snake toxins associated with a mechanism of accelerated evolution?
M Ohno, R Ménez, T Ogawa, et al.
Circulation
|
April 15, 1997
Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease
H Morita, J Taguchi, H Kurihara, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
March 10, 1979
[Relationship between body surface isopotential distribution and transmission process of pericardial membrane excitation--with special reference to atrial septal defects]
H Oguri, T Koube, M Ohno, et al.
Journal of Cardiology
|
June 1, 1997
[Gene Polymorphism of 5, 10-methylenetetrahydrofolate reductase as a coronary risk factor]
H Morita, J Taguchi, H Kurihara, et al.
ESMO Open
|
July 10, 2026
First-in-human phase I study of hypoxia-targeting <sup>64</sup>Cu-ATSM radioligand therapy in patients with malignant brain tumors (STAR-64)
H Kurihara, Y Narita, K Ito, et al.
Page
of 74